Gavin Hattersley - 10 Apr 2026 Form 4 Insider Report for MCCORMICK & CO INC (MKC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Apr 2026, 12:30:10 UTC
Prior SEC filing
23 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jason E. Wynn, Attorney-in-Fact

Key filing fact

Gavin Hattersley filed Form 4 for MCCORMICK & CO INC (MKC) on 13 Apr 2026.

Key facts

  • This page summarizes Gavin Hattersley's Form 4 filing for MCCORMICK & CO INC (MKC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Apr 2026, 12:30.

Change

  • Previous filing in this sequence was filed on 23 Feb 2026.
  • Current net transaction value: +$105,960.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001552809 Primary reporting owner

Hattersley Gavin

Relationship
Director
Address
24 SCHILLING ROAD, SUITE 1, HUNT VALLEY
Signature
Jason E. Wynn, Attorney-in-Fact
Signature date
13 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MKC transaction

Common Stock - Non Voting

Purchase

Transaction value
$105,960
Shares
+2,000
Change %
+221%
Price
$52.98
Shares after
2,906
Date
10 Apr 2026
Ownership
Direct
MKC holding

Common Stock - Voting

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
406
Date
10 Apr 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .